Hennion & Walsh Asset Management, Inc.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1861642
Parsippany, NJ
Position in TEVA
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$11,105,897
+$954,132 QoQ
Shares Held
327,801
-2.7% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#145
of 671 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $46,273,526 across 11 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
360,245 | $14,780,852 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
327,801 | $11,105,897 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
203,520 | $5,163,302 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
90,213 | $4,195,806 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
6,097 | $3,303,537 | |
| 6 | ALKS |
Alkermes plc.
|
47,317 | $2,479,174 | |
| 7 | VTRS |
Viatris Inc
|
104,642 | $1,661,714 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
112,893 | $1,128,930 |
All Filings in TEVA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,105,897 | 327,801 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $10,151,765 | 337,044 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,673,351 | 341,985 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $6,444,264 | 319,023 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $5,350,211 | 319,225 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,685,316 | 369,897 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $8,189,689 | 371,583 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,588,290 | 310,116 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $4,700,783 | 289,279 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,908,945 | 206,162 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,651,691 | 158,208 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $893,571 | 87,605 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $355,272 | 47,181 | Shares | Sole | 2023-08-09 | |
| 2021-09-30 | $1,226,392 | 125,913 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,300,345 | 131,348 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,512,259 | 131,045 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||